Press Releases

May 03, 2005 Chronic Fatigue Syndrome Presented at Symposium in New York

Apr 11, 2005 Hemispherx Biopharma's Investigational Drug Increases Physical Performance in New Chronic Fatigue Syndrome (CFS) Clinical Study

Mar 30, 2005 Hemispherx Biopharma to Present New Phase III Results in Chronic Fatigue Syndrome Treatment at 18th International Conference on Antiviral Research

Mar 21, 2005 Hemispherx Biopharma Inc. Appoints Steven D. Spence to the Board of Directors

Feb 24, 2005 Hemispherx Biopharma's Alferon N® Highlighted as Potential New Therapy for Avian Influenza on CNBC's "Closing Bell"

Feb 14, 2005 HEMISPHERX BIOPHARMA, INC. ELECTS PRESIDENT AND CHIEF OPERATING OFFICER

Feb 07, 2005 HEMISPHERX BIOPHARMA EXPANDS EVALUATION OF ALFERON N AGAINST AVIAN FLU

Jan 03, 2005 HEMISPHERX BIOPHARMA INITIATES ENROLLMENT IN HIV/HEP-C CLINICAL PROGRAM

Dec 27, 2004 HEMISPHERX BIOPHARMA FILES LAWSUIT IN FEDERAL COURT ALLEGING CONSPIRACY BY FOREIGN NATIONALS TO MANIPULATE ITS STOCK PRICE AND ENGAGE IN ILLEGAL HOSTILE TAKEOVER

Dec 21, 2004 Los Angeles Times Article Focuses on Hemispherx Biopharma's Experimental Drug Ampligen as a Potential New Therapy for Chronic Fatigue Syndrome

59 60 61 62 63 64 65 66 67 68 69

<< < > >>